Teva's Duvakitug Set To Shake Up IBD Treatment, Analyst Highlights Competitive Data
Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...
Pharm Exec1h
Treating Disruptive Symptom’s in Crohn’s Patients: Q&A with Mark Genovese, MD
Mark Genovese: Crohn’s disease is a chronic, inflammatory bowel disease associated with progressive bowel damage, disability, ...
Palatin gears up for obesity treatment trials in 2025
Inc. (NYSE American: PTN), a small-cap biotech company with a market capitalization of $20.4 million, has announced its corporate milestones for 2025, focusing on the development of treatments for ...
Future Market Insights23h
Stoma/Ostomy Care Industry to Reach USD 6.5 Billion by 2033, Growing at a 4.9% CAGR Amid Rising Prevalence of IBD and Advancements in Medical Devices
The stoma/ostomy care market is projected to grow at a 4.9% CAGR, reaching USD 6.5 billion by 2033. The rising prevalence of ...